BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37748692)

  • 1. Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function.
    Chen MF; Harada G; Liu D; DeMatteo R; Falcon C; Wilhelm C; Kris MG; Drilon A; Gutgarts V
    J Thorac Oncol; 2024 Jan; 19(1):153-159. PubMed ID: 37748692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to use… serum creatinine, cystatin C and GFR.
    Pasala S; Carmody JB
    Arch Dis Child Educ Pract Ed; 2017 Feb; 102(1):37-43. PubMed ID: 27647862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C-calculated Glomerular Filtration Rate-A Marker of Early Renal Dysfunction in Patients With Neuropathic Bladder.
    Dangle PP; Ayyash O; Kang A; Bates C; Fox J; Stephany H; Cannon G
    Urology; 2017 Feb; 100():213-217. PubMed ID: 27542858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology report.
    Christofyllakis K; Monteiro AR; Cetin O; Kos IA; Greystoke A; Luciani A
    J Geriatr Oncol; 2022 Nov; 13(8):1071-1083. PubMed ID: 35525790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
    West M; Kirby A; Stewart RA; Blankenberg S; Sullivan D; White HD; Hunt D; Marschner I; Janus E; Kritharides L; Watts GF; Simes J; Tonkin AM;
    J Am Heart Assoc; 2022 Mar; 11(5):e020745. PubMed ID: 35179040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Cancer Therapies Causing Elevations in Serum Creatinine Through Tubular Secretion Inhibition: A Case Report and Review of the Literature.
    Mach T; Qi A; Bouganim N; Trinh E
    Can J Kidney Health Dis; 2022; 9():20543581221106246. PubMed ID: 35756332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients.
    Ustundag Y; Samsar U; Acikgoz S; Cabuk M; Kiran S; Kulah E; Aydemir S
    Clin Chem Lab Med; 2007; 45(7):890-4. PubMed ID: 17617033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
    Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
    J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C versus serum creatinine in the estimation of glomerular filtration rate in rhabdomyolysis.
    Yap M; Lamarche J; Peguero A; Courville C
    J Ren Care; 2011 Sep; 37(3):155-7. PubMed ID: 21810197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of MDRD and the old CKD-EPI equations with the new CKD-EPI equations in kidney transplant patients when glomerular filtration rate is measured with 51Cr-EDTA.
    Borrego Utiel FJ; Ramírez Navarro AM; Esteban de la Rosa R; Bravo Soto JA
    Nefrologia (Engl Ed); 2020; 40(1):53-64. PubMed ID: 31843209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine.
    Herget-Rosenthal S; Pietruck F; Volbracht L; Philipp T; Kribben A
    Clin Nephrol; 2005 Jul; 64(1):41-6. PubMed ID: 16047644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.
    Bölke E; Schieren G; Gripp S; Steinbach G; Peiper M; Orth K; Matuschek C; Pelzer M; Lammering G; Houben R; Antke C; Rump LC; Mota R; Gerber PA; Schuler P; Hoffmann TK; Rusnak E; Hermsen D; Budach W
    Strahlenther Onkol; 2011 Mar; 187(3):191-201. PubMed ID: 21359659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
    Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H
    J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and renal function in pediatric kidney transplant recipients.
    Franco MC; Nagasako SS; Machado PG; Nogueira PC; Pestana JO; Sesso R
    Braz J Med Biol Res; 2009 Dec; 42(12):1225-9. PubMed ID: 19882084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients.
    Savaj S; Shoushtarizadeh T; Abbasi MA; Razavimanesh SH; Ghods AJ
    Iran J Kidney Dis; 2009 Oct; 3(4):234-8. PubMed ID: 19841528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C as a risk factor for outcomes in chronic kidney disease.
    Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
    Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
    Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients.
    Pöge U; Stoschus B; Stoffel-Wagner B; Gerhardt T; Klehr HU; Sauerbruch T; Woitas RP
    Kidney Blood Press Res; 2003; 26(1):55-60. PubMed ID: 12697978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.